Bengaluru-based hospital Cytecare on Friday announced to have introduced Digital Breast Tomosynthesis, or 3D-mammography, which creates three-dimensional images of the breast used to detect lump or other signs of breast cancer in women.
The technology uses several low dose x-rays obtained at different angles to create multiple images or “sequential slices” that step through the breast tissue and allows radiologists to see more clearly.
Speaking about it, Dr Mukta Mahajan, consultant radiologist-breast imaging and intervention, Cytecare Hospital, said: “3D mammography will have large impact on decreasing unnecessary recalls or biopsies. This will serve as an excellent problem solving tool and reduces misdiagnoses.”
According to Dr Mahajan, majority of women in India are not aware of the technology and expertise available in the field of breast cancer diagnosis.
As per the statistics published in the Asia Pacific Journal of Clinical Oncology, breast cancer has been ranked as the number one cancer among Indian women with age adjusted rate as high as 25.8 per 100,000 women. Further projection suggests that the number is likely to go as high as 1,797,900 by 2020.
“There is no organised national or regional breast cancer screening programme in India. Though there has been an increase in health check-ups among women recently, we can still see that screening is low on priority even in major cities,” Dr Mahajan said.
Various studies suggest that 3D mammography is linked with reduced percentage of missed cancers by as much as 15 per cent.